| Budget Amount *help |
¥18,330,000 (Direct Cost: ¥14,100,000、Indirect Cost: ¥4,230,000)
Fiscal Year 2011: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2010: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2009: ¥11,180,000 (Direct Cost: ¥8,600,000、Indirect Cost: ¥2,580,000)
|
|---|
| Research Abstract |
The aim of this study was to develop a new method of inhibiting the invasion and metastasis of oral squamous cell carcinoma (OSCC) through the activating Lin7C-CASK-βcatenin (LCB) pathway. In Lin7C-overexpressed OSCC cells, CASK andβcatenin levels are significantly higher than that in Mock-transfected cells. In addition, we identified HTR2C in some molecules of upstream of LCB pathway by the Ingenuity Pathway Analysis. We demonstrated that the specific HTR2C inhibitor closely related to LCB pathway, and therefore might be a therapeutic tool for cancer invasion and metastasis.
|
